Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation

2021 ◽  
pp. 1-20
Author(s):  
Wolfgang J. Streit ◽  
Jonas Rotter ◽  
Karsten Winter ◽  
Wolf Müller ◽  
Habibeh Khoshbouei ◽  
...  

Background: Neuritic plaques contain neural and microglial elements, and amyloid-β protein (Aβ), but their pathogenesis remains unknown. Objective: Elucidate neuritic plaque pathogenesis. Methods: Histochemical visualization of hyperphosphorylated-tau positive (p-tau+) structures, microglia, Aβ, and iron. Results: Disintegration of large projection neurons in human hippocampus and neocortex presents as droplet degeneration: pretangle neurons break up into spheres of numerous p-tau+ droplets of various sizes, which marks the beginning of neuritic plaques. These droplet spheres develop in the absence of colocalized Aβ deposits but once formed become encased in diffuse Aβ with great specificity. In contrast, neurofibrillary tangles often do not colocalize with Aβ. Double-labelling for p-tau and microglia showed a lack of microglial activation or phagocytosis of p-tau+ degeneration droplets but revealed massive upregulation of ferritin in microglia suggesting presence of high levels of free iron. Perl’s Prussian blue produced positive staining of microglia, droplet spheres, and Aβ plaque cores supporting the suggestion that droplet degeneration of pretangle neurons in the hippocampus and cortex represents ferroptosis, which is accompanied by the release of neuronal iron extracellularly. Conclusion: Age-related iron accumulation and ferroptosis in the CNS likely trigger at least two endogenous mechanisms of neuroprotective iron sequestration and chelation, microglial ferritin expression and Aβ deposition, respectively, both contributing to the formation of neuritic plaques. Since neurofibrillary tangles and Aβ deposits colocalize infrequently, tangle formation likely does not involve release of neuronal iron extracellularly. In human brain, targeted deposition of Aβ occurs specifically in response to ongoing ferroptotic droplet degeneration thereby producing neuritic plaques.

2008 ◽  
Vol 205 (12) ◽  
pp. 2781-2789 ◽  
Author(s):  
Hong Qing ◽  
Guiqiong He ◽  
Philip T. T. Ly ◽  
Christopher J. Fox ◽  
Matthias Staufenbiel ◽  
...  

Neuritic plaques in the brains are one of the pathological hallmarks of Alzheimer's disease (AD). Amyloid β-protein (Aβ), the central component of neuritic plaques, is derived from β-amyloid precursor protein (APP) after β- and γ-secretase cleavage. The molecular mechanism underlying the pathogenesis of AD is not yet well defined, and there has been no effective treatment for AD. Valproic acid (VPA) is one of the most widely used anticonvulsant and mood-stabilizing agents for treating epilepsy and bipolar disorder. We found that VPA decreased Aβ production by inhibiting GSK-3β–mediated γ-secretase cleavage of APP both in vitro and in vivo. VPA treatment significantly reduced neuritic plaque formation and improved memory deficits in transgenic AD model mice. We also found that early application of VPA was important for alleviating memory deficits of AD model mice. Our study suggests that VPA may be beneficial in the prevention and treatment of AD.


2006 ◽  
Vol 106 (2) ◽  
pp. 230-237 ◽  
Author(s):  
Ju Yeon Ban ◽  
Soon Ock Cho ◽  
Sang Bum Koh ◽  
Kyung-Sik Song ◽  
KiWhan Bae ◽  
...  

2007 ◽  
Vol 420 (2) ◽  
pp. 184-188 ◽  
Author(s):  
Ju Yeon Ban ◽  
Soon Ock Cho ◽  
So-Young Jeon ◽  
KiHwan Bae ◽  
Kyung-Sik Song ◽  
...  

2019 ◽  
Vol 42 (11) ◽  
pp. 1942-1946 ◽  
Author(s):  
Mami Iwasaki ◽  
Naotaka Izuo ◽  
Yasuhiko Izumi ◽  
Yuki Takada-Takatori ◽  
Akinori Akaike ◽  
...  

2009 ◽  
Vol 24 (S1) ◽  
pp. S102-S108 ◽  
Author(s):  
Hao-Yuan Cheng ◽  
Ming-Tsuen Hsieh ◽  
Fan-Shiu Tsai ◽  
Chi-Rei Wu ◽  
Chuan-Sung Chiu ◽  
...  

2003 ◽  
Vol 959 (2) ◽  
pp. 328-335 ◽  
Author(s):  
Tatsurou Yagami ◽  
Hitoshi Nakazato ◽  
Keiichi Ueda ◽  
Kenji Asakura ◽  
Takayuki Kuroda ◽  
...  

Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2860
Author(s):  
Shih-Wei Lin ◽  
You-Shan Tsai ◽  
Yen-Lien Chen ◽  
Ming-Fu Wang ◽  
Chin-Chu Chen ◽  
...  

(1) Background: An age-related cognitive decline is commonly affecting the life of elderly with symptoms involved in progressive impairments to memory and learning. It has been proposed that probiotics could modulate age-related neurological disorders via the gut–brain axis. (2) Methods: To investigate the anti-aging effect of probiotic Lactobacillus plantarum GKM3, both survival tests and cognitive experiments were conducted in the SAMP8 mice model. The six-month-old SAMP8 (n = 20 in each gender) were fed with probiotic GKM3 at a dosage of 5.1 × 109 and 1.0 × 109 cfu/ kg B.W./day until their natural death. Then, the life span was investigated. Three-month-old SAMP8 (n = 10 in each gender) were administered GKM3 for 14 weeks. Then, the behavior tests and oxidation parameters were recorded. (3) Results: GKM3 groups showed significantly increased latency in the passive avoidance test and time of successful avoidance in the active avoidance test. The TBARS and 8-OHdG from mice brains also showed a significant reduction in the groups treated with GKM3. In addition, lower accumulation of the amyloid-β protein was found in SAMP8 mice brains with the supplement of GKM3. (4) Conclusions: These results indicated that L. plantarum GKM3 delayed the process of aging, alleviated age-related cognitive impairment, and reduced oxidative stress.


Sign in / Sign up

Export Citation Format

Share Document